Cytek Biosciences, Inc. (CTKB) Stock Overview
Explore Cytek Biosciences, Inc.’s financial performance, market position, analyst ratings, and future outlook.
Cytek Biosciences, Inc. (CTKB)
Key Financials
Key Financials
Market Cap
578.6M
P/E Ratio
-7.73
EPS (TTM)
$-0.13
ROE
-0.21%
CTKB Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Cytek Biosciences, Inc. (CTKB) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 60.45, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $5.21.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -7.73 and a market capitalization of 578.6M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.